Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis

Geoffrey Pavaut; Maeva Kyheng; Olivier Le Rouzic; Thierry Perez; Benoit Wallaert; Anne Prevotat

doi:10.1183/23120541.00382-2020

Predictors of massive haemoptysis after a first episode of mild-to-moderate haemoptysis in patients with cystic fibrosis

ERJ Open Res. 2020 Sep 14;6(3):00382-2020. doi: 10.1183/23120541.00382-2020. eCollection 2020 Jul.

Authors

Geoffrey Pavaut¹, Maeva Kyheng^{2

3}, Olivier Le Rouzic^{1

4

5}, Thierry Perez^{1

4

5}, Benoit Wallaert^{1

4

5}, Anne Prevotat^{1

4

5}

Affiliations

¹ CHU Lille, Centre de Ressources et de Compétences de la Mucoviscidose, Service de Pneumologie et Immuno-allergologie, Hôpital Calmette, Lille, France.
² Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, Lille, France.
³ CHU Lille, Département de Biostatistiques, Lille, France.
⁴ Univ. Lille, Lille, France.
⁵ Inserm, CNRS, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.

Abstract

Mild-to-moderate haemoptysis (m-mH) is common in patients with cystic fibrosis but the risk of subsequent massive haemoptysis (MH) is not known. Allergic bronchopulmonary aspergillosis and diabetes were significant predictors of MH subsequent to m-mH. https://bit.ly/30093Hw.